Please login to the form below

Not currently logged in
Email:
Password:

Everyday Health appoints PHCG president

Michael du Toit to take up same position
Michael du Toit

Digital health and wellness company Everyday Health has named Michael du Toit as its president.

Du Toit has more than 30 years of experience in healthcare and consumer media and marketing and joins from Publicis Healthcare Communications Group (PHCG), where he served as global group president.

He has previously held executive roles at marketing agencies such as Digitas Health, where he was a founding member, Razorfish Health, Grey Advertising and Ventiv Health Communications.

Du Toit has additionally held senior marketing positions at pharma companies including GlaxoSmithKline and Boehringer Ingelheim.

Commenting on his appointment, du Toit said: “I am honoured to join Everyday Health and believe it has a unique set of capabilities and assets to win in the marketplace.

“I see great opportunities across the dynamic digital health landscape to further expand Everyday Health's consumer and professional business and I am very excited to get started.”

In the newly created role, du Toit will be responsible for managing and directing the strategy for the consumer and professional business including product, editorial, sales and sales development.

He will also be expected to guide Everyday Health's strategic direction and growth and ensure the company's growth in the market.

Ben Wolin, CEO and co-founder of Everyday Health, added: “We are thrilled to have Michael join our team as president and we are very confident his strong background, passion and experience make him perfectly suited to lead the continued growth of our consumer and healthcare professional businesses.”

18th February 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics